CervoMed Inc. (CRVO) stock
CRVONasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.46+0.13 (+9.77%)
Close on Nov 20, 2026Market cap $22.07MP/E –Yield –
CervoMed net income
Net income is the profit left for shareholders after every expense, interest and tax.
CervoMed's net income for the twelve months ending Jun 30, 2026 was -$30.35M. For fiscal 2025 it was -$26.97M. The highest annual figure on record is -$1.36M in fiscal 2017.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$26.97M | – |
| FY2024 | Dec 31, 2024 | -$16.29M | – |
| FY2023 | Dec 31, 2023 | -$2.17M | – |
| FY2022 | Dec 31, 2022 | -$5.80M | – |
| FY2021 | Dec 31, 2021 | -$24.10M | – |
| FY2020 | Dec 31, 2020 | -$14.19M | – |
| FY2019 | Dec 31, 2019 | -$11.80M | – |
| FY2018 | Dec 31, 2018 | -$18.37M | – |
| FY2017 | Dec 31, 2017 | -$1.36M | – |
| FY2016 | Dec 31, 2016 | -$18.04M | – |
| FY2015 | Dec 31, 2015 | -$6.72M | – |
| FY2014 | Dec 31, 2014 | -$14.35M | – |
| FY2013 | Dec 31, 2013 | -$2.46M | – |
| FY2012 | Dec 31, 2012 | -$6.87M | – |
| FY2011 | Dec 31, 2011 | -$22.64M | – |
| FY2010 | Dec 31, 2010 | -$8.41M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.57M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.96M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.09M | – |
| Q3 FY2025 | Sep 30, 2025 | -$7.73M | – |
| Q2 FY2025 | Jun 30, 2025 | -$6.26M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.89M | – |
| Q4 FY2024 | Dec 31, 2024 | -$6.71M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.75M | -321.1% |
| Q2 FY2024 | Jun 30, 2024 | -$2.32M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.51M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.36M | – |
| Q3 FY2023 | Sep 30, 2023 | $2.15M | – |
| Q2 FY2023 | Jun 30, 2023 | -$1.43M | – |
| Q1 FY2023 | Mar 31, 2023 | -$534.34K | – |
| Q4 FY2022 | Dec 31, 2022 | -$1.53M | – |
| Q3 FY2022 | Sep 30, 2022 | -$882.62K | – |
| Q2 FY2022 | Jun 30, 2022 | -$4.19M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.53M | – |
| Q4 FY2021 | Dec 31, 2021 | -$3.47M | – |
| Q3 FY2021 | Sep 30, 2021 | -$12.20M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.78M | – |
| Q1 FY2021 | Mar 31, 2021 | -$4.64M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.44M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.13M | – |
| Q1 FY2020 | Mar 31, 2020 | -$2.56M | – |
| Q4 FY2019 | Dec 31, 2019 | -$3.75M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.80M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.50M | – |
| Q1 FY2019 | Mar 31, 2019 | -$2.75M | – |
| Q4 FY2018 | Dec 31, 2018 | -$5.57M | -411.3% |
| Q3 FY2018 | Sep 30, 2018 | -$6.72M | -231.8% |
| Q2 FY2018 | Jun 30, 2018 | -$2.77M | -113.6% |
| Q1 FY2018 | Mar 31, 2018 | -$3.31M | – |
| Q4 FY2017 | Dec 31, 2017 | $1.79M | – |
| Q3 FY2017 | Sep 30, 2017 | $5.10M | – |
| Q2 FY2017 | Jun 30, 2017 | $20.39M | – |
| Q1 FY2017 | Mar 31, 2017 | -$28.64M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.57M | – |
| Q3 FY2016 | Sep 30, 2016 | -$5.44M | – |
See a number that looks wrong?